Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Diaphragm function after an interscalene block with liposomal bupivacaine

Official title: Evaluation of Diaphragmatic Function After Interscalene Brachial Plexus Block With Liposomal Bupivacaine: A Cohort Study

Run by Zhejiang University · NCT07263295 · Data updated 2026-11-12

This study tests whether liposomal bupivacaine used with an interscalene block affects diaphragmatic function in adults having upper limb surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorZhejiang University
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedDecember 5, 2025
Main results expectedAugust 20, 2026
Study endsAugust 25, 2026
Registry record updatedAugust 3, 2026
Trial IDNCT07263295 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) scheduled for upper limb surgery with planned interscalene block and ASA I–III.

Probably not a fit

Patients with preexisting pulmonary disease or other contraindications may not benefit and could be at higher risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares two local anesthetic approaches for interscalene brachial plexus block in adults undergoing upper limb surgery. Group A receives 20 mL of 0.5% plain bupivacaine, while Group B receives 10 mL of 0.5% plain bupivacaine plus 10 mL of liposomal bupivacaine. Researchers will assess diaphragmatic and pulmonary function and pain at baseline and multiple time points after the block, with monitoring for adverse events. The study plans to enroll 120 participants and run from 2025 to 2026 under standard ethical and privacy protections. Outcomes focus on diaphragmatic preservation and respiratory impact alongside analgesia.

Why it matters

Potential benefit: If liposomal bupivacaine helps maintain diaphragmatic function, patients may experience better breathing after surgery and potentially less respiratory complication.

How similar studies have gone: Previous regional anesthesia studies have explored diaphragmatic effects of interscalene blocks, with mixed results; this trial builds on that by comparing formulations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing upper limb surgery scheduled for interscalene brachial plexus block
* Aged ≥ 18 years
* American Society of Anesthesiologists (ASA) physical status I-III

Exclusion Criteria:

* Known allergy or intolerance to amide local anesthetics
* Nerve injury in the upper limb on the surgical side
* Coagulopathy
* Used opioid medications continuously for more than 3 weeks before surgery
* History of pulmonary disease and a pulse oxygen saturation (SpO₂) \< 95% (measured after 5 minutes of rest at room temperature without oxygen supplementation, using a transcutaneous pulse oximeter)
* Refuse to participate or are deemed unsuitable for this trial by the researchers

Withdrawal Criteria:

* Patients voluntarily withdrew their informed consent
* Surgery was canceled or the anesthesia method was changed due to surgical factors before interscalene brachial plexus block

Where it's running

  • The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, zhejiang 310000
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.